SDEA

Innovative Pharmacovigilance in the GCC: Digital, Patient-Centric, Compliant

Leave a Comment / Uncategorized / 7fiza0177@gmail.com

GCC pharmacovigilance is evolving with digital tools, patient-centric focus, and strict compliance to SFDA GVP and UAE MoHAP guidelines, enhancing drug safety, risk management, and market access.

Innovative Pharmacovigilance in the GCC: Digital, Patient-Centric, Compliant Read More »

Building Reliable Pharmacovigilance Systems in Complex Markets: A GCC and Middle East Blueprint

Leave a Comment / Uncategorized / 7fiza0177@gmail.com

This blueprint guides building compliant pharmacovigilance systems in the Middle East/GCC by navigating regional regulations, establishing robust QMS, validating safety databases, and ensuring operational excellence in safety reporting.

Building Reliable Pharmacovigilance Systems in Complex Markets: A GCC and Middle East Blueprint Read More »